Nanosphere Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 142

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $92.4M

Nanosphere General Information

Description

molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in disease detection, optimal patient treatment and improved healthcare economics.

Contact Information

Website
www.nanosphere.us
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Social/Platform Software
Acquirer
Luminex
Primary Office
  • 4088 Commercial Avenue
  • Northbrook, IL 60062
  • United States
+1 (847) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 30-Jun-2016 $92.4M 00000 000.00 Completed Generating Revenue
11. Secondary Transaction - Open Market 17-May-2016 00000 Completed Generating Revenue
10. Secondary Transaction - Open Market 31-Dec-2015 00000 Completed Generating Revenue
9. PIPE 11-May-2015 00.00 00000 Completed Generating Revenue
8. Debt - General 07-May-2015 0000 00000 Completed Generating Revenue
7. PIPE 19-Jul-2012 0000 00000 Completed Generating Revenue
6. IPO 01-Nov-2007 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 26-Apr-2006 0000 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C2) 14-Oct-2004 $17M $44.4M 000.00 Completed Startup
3. Later Stage VC (Series C) 26-Nov-2002 $15M $27.4M 000.00 Completed Startup
To view Nanosphere’s complete valuation and funding history, request access »

Nanosphere Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C2 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 10,066,673 $0.010000 8% $0.6 $0.6 1x $0.6 2.24%
Series B 17,007 $0.010000 8% $2.21 $2.21
To view Nanosphere’s complete cap table history, request access »

Nanosphere Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in di
Decision/Risk Analysis
Northbrook, IL
142 As of 2016
00000
00.00 0000-00-00
000000&0 00000

000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
00000 0000000000 000
Oakland, CA
00 As of 0000
000.00
00000000000 000.00

000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
00000 0000000000 000
Oklahoma City, OK
00 As of 0000
00.00
000 0000-00-00
00000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanosphere Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fabric Genomics Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Oklahoma City, OK 00 00.00 00000000000 00.00
00000000 Formerly VC-backed Austin, TX 000 000.00 000000&0 000.00
00000000 000000000 Venture Capital-Backed Broomfield, CO 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Chicago, IL 0000 00.000 000000000 00 00.000
You’re viewing 5 of 8 competitors. Get the full list »

Nanosphere Executive Team (13)

Name Title Board Seat Contact Info
Kenneth Bahk Ph.D Chief Strategy Officer
You’re viewing 1 of 13 executive team members. Get the full list »

Nanosphere Board Members (8)

Name Representing Role Since
Gene Cartwright Self Board Member 000 0000
Lorin Randall Self Board Member 000 0000
R. Holmlin Ph.D Self Director 000 0000
You’re viewing 3 of 8 board members. Get the full list »

Nanosphere Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanosphere Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Allen & Company Investment Bank Minority 000 0000 000000 0
Bain Capital Ventures Venture Capital Minority 000 0000 000000 0
Lurie Investment Fund Corporate Venture Capital Minority 000 0000 000000 0
NGEN MGT II Venture Capital Minority 000 0000 000000 0
Oxford Finance Lender/Debt Provider 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Nanosphere Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (00 18-Aug-2010 000000000 000 Buildings and Property
To view Nanosphere’s complete investments history, request access »

Ready to get started?

Request a free trial